Crest Clinical Services Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.50 M
as on 03-12-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 168.32%
(FY 2022)
- Profit 70.25%
(FY 2022)
- Ebitda 94.08%
(FY 2022)
- Net Worth -1.68%
(FY 2022)
- Total Assets -1.52%
(FY 2022)
About Crest Clinical Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajasekara Madarasu, Srinivas Samavedam, Ganshyam Jagathkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100TG2009PTC065825
- Company No.
065825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crest Clinical Services?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajasekara Madarasu  | Director | 13-Nov-2009 | Current |
| Ganshyam Jagathkar | Director | 13-Nov-2009 | Current |
| Srinivas Samavedam | Director | 13-Nov-2009 | Current |
| Pakanati Reddy | Director | 01-Aug-2013 | Current |
Financial Performance and Corporate Structure Insights of Crest Clinical Services.
Crest Clinical Services Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 168.32% increase. The company also saw a substantial improvement in profitability, with a 70.25% increase in profit. The company's net worth dipped by a decrease of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crest Clinical Services?
In 2020, Crest Clinical Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Renown Clinical Services Private LimitedActive 9 years 16 daysRajasekara Madarasu is a mutual person
Hics Academy Of Critical Care LlpActive 1 year 4 monthsSrinivas Samavedam and Ganshyam Jagathkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crest Clinical Services?
Unlock and access historical data on people associated with Crest Clinical Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crest Clinical Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crest Clinical Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
